Atlas Trials

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

Clinical trial NCT03168737 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03168737
Sponsor
M.D. Anderson Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant Breast NeoplasmMalignant Colorectal NeoplasmMalignant Pancreatic NeoplasmMalignant Solid Neoplasm
Start date
2017-09-22
Primary completion
2027-04-30
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.